Report indicates shift in strategy

Share this article:
A report released by Best Practices indicates that leading pharma and biopharmaceutical companies are rethinking their publication strategies, in light of new transparency guidelines.

“Traditional, global peer-reviewed journals remain the first choice of most companies at all phases of product development, but companies are increasingly exploring alternative media for scientific publications—50% of benchmark participants said they will be increasing the percentage of articles they submit to alternative media, such as e-journals, compared with 36% increasing submission to peer-reviewed journals,” said Martha Haswell, senior research analyst at Best Practices. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Email Newsletters